33 Chimerix's (CMRX) recently approved "weaponized smallpox" vaccine (Brincidofovir) has previously failed TWO different Phase 3 trials with all-cause deaths in the treatment group occurring at 150% of the rate for placebo group, 15% versus 10%. (www.fiercebiotech.com) posted 3 years ago by Error_usernotfound 3 years ago by Error_usernotfound +33 / -0 8 comments share 8 comments share save hide report block hide replies
Yay smallpox, the seasonal flu thing was such a dud.
All with BARPA, the biomedical version of DARPA.
SIGA also had an approved smallpox medication TPOXX approved 2018.
Haven't started down the Siga rabbit hole yet. Still digging up stuff on Chimerix.
This is so fucked up...
Brand name is Tembexa *Notice the disclaimer about increased mortality rates
Chimerix licensed Cidofovir from Gilead Sciences and received funding from NIH
former Chimerix CEO George Painter connected to new pill-based COVID-19 treatment
Chimerix has ties to Bilderberg Group, Rumsfeld, and Council on Foreign Relations, Dr. Ralph Baric...just to name a few. SOURCE: opencorporates, lilsis, and brave search.
So this stock is a buy buy buy?